- •Thromboelastography (TEG) does not reliably assess novel oral anticoagulants (NOAC)-related coagulopathy in traumatic brain injury patients.
- •Caution should be used when utilizing TEG to assess anticoagulation status.
- •The development of a NOAC specific assay is needed to improve the accuracy of TEG.
- •PCC4 administration may not be necessary for patients with a traumatic brain injury on NOAC therapy.
Purchase one-time access:Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
One-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
- National center for health statistics: mortality data on CDC WONDER.(Available at:)https://wonder-cdc-gov.evms.idm.oclc.org/mcd.htmlDate accessed: February 7, 2022
- Novel oral anticoagulants: clinical pharmacology, indications and practical considerations.Eur J Clin Pharmacol. 2013; 69: 1617-1633
- Novel oral anticoagulants and trauma: the results of a prospective American association for the surgery of trauma multi-institutional trial.J Trauma Acute Care Surg. 2017; 82: 827-835
- Determination of non-Vitamin K oral anticoagulant (NOAC) effects using a new-generation thrombelastography TEG 6s system.J Thromb Thrombolysis. 2017; 43: 437-445
- TEG® and RapidTEG® are unreliable for detecting warfarin-coagulopathy: a prospective cohort study.Thromb J. 2014; 12: 4
- Use of thromboelastography (TEG) for detection of new oral anticoagulants.Arch Pathol Lab Med. 2015; 139: 665-673
- Comparison of proportions calculator.(Available at:)https://www.medcalc.org/calc/comparison_of_proportions.phpDate accessed: February 7, 2022
- Laboratory measures of coagulation among trauma patients on NOAs: results of the AAST-MIT.Trauma Surg Acute Care Open. 2018; 3: e000231